Tag #Pharmaceuticals

Showing 109 to 120 of 151 results

china.org.cn

🌐 85% Global Worthiness

Jan 4, 07:10

China's Plan to Become a Pharmaceutical Powerhouse by 2035

China's State Council issued a guideline to transform its pharmaceutical industry into a global powerhouse by 2035, outlining 24 reform measures to enhance innovation, improve regulatory efficiency, and strengthen safety and quality controls, with 2024 showing 48 innovative drugs and 65 medical devi...

China's Plan to Become a Pharmaceutical Powerhouse by 2035

China's State Council issued a guideline to transform its pharmaceutical industry into a global powerhouse by 2035, outlining 24 reform measures to enhance innovation, improve regulatory efficiency, and strengthen safety and quality controls, with 2024 showing 48 innovative drugs and 65 medical devi...

Progress

44% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What specific steps is China taking to become a leading pharmaceutical innovator by 2035?

China aims to transform its pharmaceutical industry into a global powerhouse by 2035, focusing on improving regulatory frameworks, enhancing review and approval processes, and strengthening whole-lifecycle regulation to ensure product safety and quality. In 2024 alone, 48 innovative drugs and 65 innovative medical devices gained market approval.

dw.com

🌐 85% Global Worthiness

Dec 25, 13:07

Medical Breakthroughs Offer Hope for AIDS, Schizophrenia, and Alzheimer's

New semi-annual HIV treatment lenacapavir, novel schizophrenia drug 'Copenfi', and Alzheimer's drug Lecanemab offer hope but face cost and accessibility challenges.

Medical Breakthroughs Offer Hope for AIDS, Schizophrenia, and Alzheimer's

New semi-annual HIV treatment lenacapavir, novel schizophrenia drug 'Copenfi', and Alzheimer's drug Lecanemab offer hope but face cost and accessibility challenges.

Progress

40% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the most significant advancements in treating AIDS, schizophrenia, and Alzheimer's, and what are their immediate impacts?

New treatments for AIDS, schizophrenia, and Alzheimer's are now available. A new semi-annual AIDS treatment, lenacapavir, offers effective HIV prevention and is easier to administer than other treatments. A novel schizophrenia drug, 'Copenfi,' targets different receptors than existing medications, potentially changing treatment paradigms.",

forbes.com

🌐 85% Global Worthiness

Dec 23, 22:08

Pharmaceutical Industry Faces 2025 Inflection Point Amidst Global Cost Pressures

Global pharmaceutical manufacturers face increasing pressure to lower drug prices in 2025 due to government regulations (e.g., the Inflation Reduction Act), payer consolidation, and consumer cost concerns; requiring manufacturers to prioritize long-term value, evidence-based decision-making, and str...

Pharmaceutical Industry Faces 2025 Inflection Point Amidst Global Cost Pressures

Global pharmaceutical manufacturers face increasing pressure to lower drug prices in 2025 due to government regulations (e.g., the Inflation Reduction Act), payer consolidation, and consumer cost concerns; requiring manufacturers to prioritize long-term value, evidence-based decision-making, and str...

Progress

44% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the most significant challenges facing the pharmaceutical industry in 2025, and what immediate actions must manufacturers take to address them?

The pharmaceutical industry faces significant challenges in 2025 due to global cost pressures and evolving political landscapes. Governments and private payers are demanding lower drug prices, increasing evidentiary requirements for market entry, and implementing price controls. This necessitates manufacturers to fundamentally rethink their models, prioritizing long-term value and strategic collaborations.

cnbc.com

🌐 75% Global Worthiness

Dec 23, 22:08

Market Movers: Nordstrom Privatization, Novo Nordisk Rebound, and Tech MA

In midday trading, Nordstrom shares fell over 1% following its \$6.25 billion buyout, while Novo Nordisk shares rebounded after a previous drop; Honda surged over 11% on merger talks with Nissan; Xerox rose 7% on its Lexmark acquisition; Despegar.com soared 32% on Prosus's buyout; and Traws Pharma j...

Market Movers: Nordstrom Privatization, Novo Nordisk Rebound, and Tech MA

In midday trading, Nordstrom shares fell over 1% following its \$6.25 billion buyout, while Novo Nordisk shares rebounded after a previous drop; Honda surged over 11% on merger talks with Nissan; Xerox rose 7% on its Lexmark acquisition; Despegar.com soared 32% on Prosus's buyout; and Traws Pharma j...

Progress

16% Bias Score

ShareSaveArticle

Decent Work and Economic Growth

12345678

Previous 1 of 8 Next

What were the immediate market reactions to Nordstrom's privatization and Novo Nordisk's drug trial results?

Nordstrom is going private in a \$6.25 billion deal with its founding family and El Puerto de Liverpool, offering shareholders \$24.25 per share. Novo Nordisk shares rebounded after Friday's 18% drop following disappointing weight-loss drug trial results.

abcnews.go.com

🌐 85% Global Worthiness

Dec 19, 04:09

DOJ Sues CVS for Alleged Role in Opioid Crisis

The US Justice Department sued CVS, alleging the pharmacy chain unlawfully dispensed massive quantities of opioids and other controlled substances for over a decade, ignoring red flags and prioritizing speed over safety, contributing to the opioid crisis.

DOJ Sues CVS for Alleged Role in Opioid Crisis

The US Justice Department sued CVS, alleging the pharmacy chain unlawfully dispensed massive quantities of opioids and other controlled substances for over a decade, ignoring red flags and prioritizing speed over safety, contributing to the opioid crisis.

Progress

56% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the immediate consequences of the Justice Department's lawsuit against CVS for its alleged role in the opioid crisis?

The Justice Department filed a civil lawsuit against CVS, America's largest pharmacy chain, alleging that it unlawfully dispensed massive quantities of opioids and other controlled substances for over a decade, contributing to the opioid crisis. The suit claims CVS ignored red flags indicating illegitimate prescriptions, prioritizing speed over safety due to performance metrics and incentive policies.

forbes.com

🌐 75% Global Worthiness

Dec 18, 16:15

Pfizer Stock Up 5% on Positive 2025 Outlook

Pfizer's stock rose 5% on December 17, 2024, after projecting $61-$64 billion in 2025 revenue and $2.80-$3.00 adjusted earnings per share, driven by acquisitions and cost-cutting to offset declining Covid-19 vaccine sales.

Pfizer Stock Up 5% on Positive 2025 Outlook

Pfizer's stock rose 5% on December 17, 2024, after projecting $61-$64 billion in 2025 revenue and $2.80-$3.00 adjusted earnings per share, driven by acquisitions and cost-cutting to offset declining Covid-19 vaccine sales.

Progress

36% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the immediate impact of Pfizer's positive 2025 financial outlook on its stock price and overall market perception?

Pfizer's stock price increased by 5% on December 17th, 2024, following the announcement of a positive 2025 revenue outlook ($61B-$64B) and adjusted earnings ($2.80-$3.00 per share). This follows recent acquisitions and cost-cutting measures aimed at offsetting declining Covid-19 vaccine demand.

cnbc.com

🌐 75% Global Worthiness

Dec 29, 16:07

Biotech Stocks Poised for 2025 Rebound

Biotech stocks are poised for a rebound in 2025, driven by increased merger and acquisition activity, new drug approvals, and a looming patent cliff forcing large pharmaceutical companies to seek innovative biotech partners; however, investors should focus on specific companies rather than broad ind...

Biotech Stocks Poised for 2025 Rebound

Biotech stocks are poised for a rebound in 2025, driven by increased merger and acquisition activity, new drug approvals, and a looming patent cliff forcing large pharmaceutical companies to seek innovative biotech partners; however, investors should focus on specific companies rather than broad ind...

Progress

48% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the key factors determining which biotech companies will outperform in 2025, and what long-term trends will shape the sector's future?

The biotech sector's future trajectory hinges on several factors: the pace of M&A activity, the success of new drug approvals, and the regulatory environment. Companies with existing market positions and potential for label expansion are viewed favorably. Neurology, immunology, oncology, and metabolic diseases are expected to be attractive areas for Big Pharma acquisitions.

cnbc.com

🌐 75% Global Worthiness

Dec 24, 19:07

Quiet Christmas Eve Trading: Yields Rise, FDA Ends Zepbound Shortage

On December 24th, U.S. stock futures were mostly unchanged, while the 10-year and 30-year Treasury yields hit their highest points since May 30th and April 26th, respectively; all U.S. markets closed at 1 p.m. ET, and low trading volume is expected.

Quiet Christmas Eve Trading: Yields Rise, FDA Ends Zepbound Shortage

On December 24th, U.S. stock futures were mostly unchanged, while the 10-year and 30-year Treasury yields hit their highest points since May 30th and April 26th, respectively; all U.S. markets closed at 1 p.m. ET, and low trading volume is expected.

Progress

36% Bias Score

ShareSaveArticle

No Poverty

12345678

Previous 1 of 8 Next

What were the key market movements on December 24th, and what are their immediate implications?

U.S. stock futures showed minimal change, while oil, gold, and the dollar rose slightly. The 10-year Treasury yield reached 4.613%, its highest since May 30th, and the 30-year yield hit 4.808%, its peak since April 26th. All U.S. markets closed early at 1 p.m. ET.

cnbc.com

🌐 75% Global Worthiness

Dec 23, 19:10

Market Shows Mixed Reaction to Positive and Negative News

Mixed market reactions to recent news include slightly higher stock prices, a strengthening dollar, and decreasing oil and gold prices; Apple explores home security devices, potentially leading to record iPhone sales; labor disputes affect Amazon and Starbucks; Honda and Nissan explore a potential m...

Market Shows Mixed Reaction to Positive and Negative News

Mixed market reactions to recent news include slightly higher stock prices, a strengthening dollar, and decreasing oil and gold prices; Apple explores home security devices, potentially leading to record iPhone sales; labor disputes affect Amazon and Starbucks; Honda and Nissan explore a potential m...

Progress

44% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How do the labor disputes at major companies like Amazon and Starbucks reflect broader trends in the labor market?

The market reacted positively to recent positive news, with Apple's expansion into home security and projections of record iPhone sales contributing to the rise. Conversely, labor disputes continue at Amazon and Starbucks, highlighting ongoing challenges in the retail sector.

elmundo.es

🌐 75% Global Worthiness

Dec 20, 13:12

Spain's Methylphenidate Shortage to End in Early 2025

The Spanish Agency of Medicines and Medical Products (Aemps) reports that methylphenidate shortages for ADHD treatment, affecting patients since April 2024 due to increased global demand and production issues at Janssen-Cilag, will be resolved by early 2025 thanks to increased production from variou...

Spain's Methylphenidate Shortage to End in Early 2025

The Spanish Agency of Medicines and Medical Products (Aemps) reports that methylphenidate shortages for ADHD treatment, affecting patients since April 2024 due to increased global demand and production issues at Janssen-Cilag, will be resolved by early 2025 thanks to increased production from variou...

Progress

24% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What factors contributed to the methylphenidate shortage in Spain, and how did this impact healthcare professionals and patients?

Global demand and production limitations at Janssen-Cilag (80% market share, 12.6% lower sales in 2024) caused widespread methylphenidate shortages in Spain. This impacted other manufacturers, leading to recommendations from Aemps, AEPNyA, AEP, and SEPSM to mitigate patient impact. Liconsa's production increase aims to alleviate the shortage.

sueddeutsche.de

🌐 85% Global Worthiness

Dec 18, 16:15

dm's Online Pharmacy Entry Shakes Up German Pharmaceutical Market

dm, a German drugstore chain, plans to launch an online pharmacy for non-prescription drugs, creating competition for existing pharmacies and causing share prices of competitors to fall; the company may also expand into telemedicine and in-store vaccinations.

dm's Online Pharmacy Entry Shakes Up German Pharmaceutical Market

dm, a German drugstore chain, plans to launch an online pharmacy for non-prescription drugs, creating competition for existing pharmacies and causing share prices of competitors to fall; the company may also expand into telemedicine and in-store vaccinations.

Progress

44% Bias Score

ShareSaveArticle

Decent Work and Economic Growth

12345678

Previous 1 of 8 Next

What is the immediate impact of dm's planned online pharmacy on the German pharmaceutical market?

Germany's online non-prescription drug market reached over €6 billion in 2023. dm, a major drugstore chain, plans to enter this market, creating competition for existing online and brick-and-mortar pharmacies. This caused share prices of competitors Redcare Pharmacy and DocMorris to drop significantly.",

fr.allafrica.com

🌐 75% Global Worthiness

Dec 18, 19:12

Africa's Pharmaceutical Dependence Hinders Health Emergency Response

Michel Sidibé, former UNAIDS executive director, decried Africa's vulnerability due to its dependence on external pharmaceutical production, impacting its ability to manage health emergencies; a strategic plan targets 24 essential medicines to address this, emphasizing the need for local production ...

Africa's Pharmaceutical Dependence Hinders Health Emergency Response

Michel Sidibé, former UNAIDS executive director, decried Africa's vulnerability due to its dependence on external pharmaceutical production, impacting its ability to manage health emergencies; a strategic plan targets 24 essential medicines to address this, emphasizing the need for local production ...

Progress

44% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How does Africa's high consumption of globally produced vaccines (25%) relate to its limited pharmaceutical production capacity?

Sidibé's statement underscores a critical challenge: Africa's healthcare security is compromised by its reliance on external pharmaceutical supplies. The lack of local production capacity directly impacts the continent's ability to manage health crises effectively, as seen in its high consumption of imported vaccines despite the need for greater self-sufficiency.

Showing 109 to 120 of 151 results